Skip to main content
. 2010 Sep 27;28(31):4755–4761. doi: 10.1200/JCO.2010.30.1325

Fig 4.

Fig 4.

Estimates of disease-free survival (± SE) in 540 patients with Philadelphia chromosome–positive childhood acute lymphoblastic leukemia. The patients were classified according to modified Rome–National Cancer Institute criteria as follows: better prognosis (10 years of age or younger with a leukocyte count of < 50,000/μL), intermediate prognosis (intermediate-risk features), and worst prognosis (any age with a leukocyte count of > 100,000/μL). Five-year estimates are shown.